194 related articles for article (PubMed ID: 28726171)
1. QSAR modeling, docking and ADMET studies for exploration of potential anti-malarial compounds against Plasmodium falciparum.
Qidwai T
In Silico Pharmacol; 2016 Dec; 5(1):6. PubMed ID: 28726171
[TBL] [Abstract][Full Text] [Related]
2. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
3. 2D-quantitative structure-activity relationships model using PLS method for anti-malarial activities of anti-haemozoin compounds.
Nguyen PTV; Van Dat T; Mizukami S; Nguyen DLH; Mosaddeque F; Kim SN; Nguyen DHB; Đinh OT; Vo TL; Nguyen GLT; Quoc Duong C; Mizuta S; Tam DNH; Truong MP; Huy NT; Hirayama K
Malar J; 2021 Jun; 20(1):264. PubMed ID: 34116665
[TBL] [Abstract][Full Text] [Related]
4. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
[TBL] [Abstract][Full Text] [Related]
5. Docking Based 3D-QSAR Study of Tricyclic Guanidine Analogues of Batzelladine K As Anti-Malarial Agents.
Ahmed N; Anwar S; Thet Htar T
Front Chem; 2017; 5():36. PubMed ID: 28664157
[TBL] [Abstract][Full Text] [Related]
6. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
7. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
Thillainayagam M; Anbarasu A; Ramaiah S
J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
[TBL] [Abstract][Full Text] [Related]
8. 2,4-disubstituted 6-fluoroquinolines as potent antiplasmodial agents: QSAR, homology modeling, molecular docking and ADMET studies.
Shallangwa GA; Mahmud AW; Uzairu A; Ibrahim MT
J Taibah Univ Med Sci; 2024 Apr; 19(2):233-247. PubMed ID: 38179257
[TBL] [Abstract][Full Text] [Related]
9. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors.
Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC
Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392
[TBL] [Abstract][Full Text] [Related]
10. Highly potent anti-malarial activity of benzopyrano(4,3-b)benzopyran derivatives and
Joshi N; Hada R; Gupta S; Khan J; Dobrowolski J; Dhar PK; Kumar N; Singh S
J Biomol Struct Dyn; 2022 Jul; 40(11):5159-5174. PubMed ID: 33416018
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks.
Yousefinejad S; Mahboubifar M; Eskandari R
Malar J; 2019 Sep; 18(1):310. PubMed ID: 31521174
[TBL] [Abstract][Full Text]
